Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Sehee Kim is a leading figure in minimally invasive gynecologic and hepatopancreatobiliary surgery, with a research focus on optimizing surgical outcomes through data-driven risk stratification. Her landmark study, "The Number of Myomas Is the Most Important Risk Factor for Blood Loss and Total Operation Time in Robotic Myomectomy," analyzed 242 cases to establish that myoma count—not size or location—is the primary predictor of operative complexity. This finding has directly informed preoperative counseling and surgical planning, earning 8 citations. Dr. Kim also advanced the field of oncologic surgery with her 2022 study comparing minimally invasive versus open pancreaticoduodenectomy for distal bile duct cancer, using inverse probability of treatment weighting to demonstrate comparable oncologic outcomes with reduced morbidity. Her work bridges the gap between surgical innovation and evidence-based practice, providing clinicians with actionable metrics to improve patient safety. With a growing citation record and a reputation for rigorous methodology, Dr. Kim continues to shape the future of robotic and laparoscopic surgery, making her a vital resource for researchers and surgeons alike.